These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12673616)

  • 1. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment.
    Reif A; Hamelbeck B; Pfuhlmann B
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):356-7. PubMed ID: 12673616
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of mood-normalizing agents on cognitive functions].
    Suwalska A; Łojko D; Rybakowski J
    Psychiatr Pol; 2001; 35(2):245-56. PubMed ID: 11490889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
    Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
    Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproic acid intoxication in a patient with bipolar disorder and chronic uremia.
    Lapierre O; Dubreucq JL; Beauchemin MA; Vinet B
    Can J Psychiatry; 1999 Mar; 44(2):188. PubMed ID: 10097841
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of valproate-induced hyperammonemia.
    Stewart JT
    J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
    Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
    Laghate VD; Gupta SB
    J Assoc Physicians India; 2004 Mar; 52():257-8. PubMed ID: 15636323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic pleural effusion associated with the addition of sodium valproate.
    Fernández-Pérez R; Alvarez-Dobaño JM; Suárez-Antelo J; Codesido-Barcala R; Carballal-Calvo F; Arrojo-Romero M; de Leon J
    J Clin Psychopharmacol; 2009 Jun; 29(3):310-1. PubMed ID: 19440094
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inadequate vasopressin secretion and valproate].
    Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
    Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stupor associated with the treatment of epilepsy with valproate].
    Skjødt T; Sørensen T
    Ugeskr Laeger; 1984 Apr; 146(15):1137-8. PubMed ID: 6429914
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe leukopenia with valproate.
    Storch DD
    J Am Acad Child Adolesc Psychiatry; 2000 Oct; 39(10):1208-9. PubMed ID: 11026170
    [No Abstract]   [Full Text] [Related]  

  • 14. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increased risk of road traffic accidents after prescriptions of lithium or valproate?
    Bramness JG; Skurtveit S; Neutel CI; Mørland J; Engeland A
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):492-6. PubMed ID: 19326366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Pancreatitis Associated with Valproate Treatment.
    Quan W; Shao Q; Zhang H; Liu FH; Zhang XH
    Chin Med J (Engl); 2018 Aug; 131(15):1889-1890. PubMed ID: 30058594
    [No Abstract]   [Full Text] [Related]  

  • 17. Infiltration of sodium valproate with compartment syndrome and bullous reaction: case report and literature review.
    Santivasi WL; Kulkarni S; Patton ML; Haith LR; Guilday RE; Reigart CL; Ackerman BH
    Burns; 2011 Nov; 37(7):e59-62. PubMed ID: 21715098
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic acid-induced myopathy in a patient with schizoaffective disorder.
    Reiche I; Tröger U; Postel SC; Wolf R; Bode-Böger SM
    J Clin Psychopharmacol; 2009 Aug; 29(4):402-3. PubMed ID: 19593189
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
    Masmoudi K; Gras-Champel V; Masson H; Andréjak M
    Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: a case report in the psychiatric setting.
    Dealberto MJ; Sarazin FF
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):369-71. PubMed ID: 18806245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.